Interim joint analysis of the ABC (anthracyclines in early breast cancer) phase III trials (USOR 06-090, NSABP B-46I/USOR 07132, NSABP B-49 [NRG Oncology]) comparing docetaxel plus cyclophosphamide (TC) v anthracycline/taxane-based chemotherapy regimens (TaxAC) in women with high-risk, HER2-negative breast cancer Meeting Abstract
| Authors: | Blum, J. L.; Flynn, P. J.; Yothers, G.; Asrnar, L.; Geyer, C. E.; Jacobs, S. A.; Robert, N. J.; Atkins, J. N.; O'Shaughnessy, J.; Dang, C. T.; Gomez, H. L.; Fehrenbacher, L.; Vukelja, S. J.; Lyss, A. P.; Paul, D.; Brufsky, A. M.; Swain, S. M.; Mamounas, E. P.; Jones, S. E.; Wolmark, N. |
| Abstract Title: | Interim joint analysis of the ABC (anthracyclines in early breast cancer) phase III trials (USOR 06-090, NSABP B-46I/USOR 07132, NSABP B-49 [NRG Oncology]) comparing docetaxel plus cyclophosphamide (TC) v anthracycline/taxane-based chemotherapy regimens (TaxAC) in women with high-risk, HER2-negative breast cancer |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 43s |
| Language: | English |
| ACCESSION: | WOS:000404665401122 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.1000 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1000 -- Source: Wos |
